Literature DB >> 24626160

Respiratory phenotypes are distinctly affected in mice with common Rett syndrome mutations MeCP2 T158A and R168X.

J M Bissonnette1, L R Schaevitz2, S J Knopp3, Z Zhou4.   

Abstract

Respiratory disturbances are a primary phenotype of the neurological disorder, Rett syndrome (RTT), caused by mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MeCP2). Mouse models generated with null mutations in Mecp2 mimic respiratory abnormalities in RTT girls. Large deletions, however, are seen in only ∼10% of affected human individuals. Here we characterized respiration in heterozygous females from two mouse models that genetically mimic common RTT point mutations, a missense mutation T158A (Mecp2(T158A/)(+)) or a nonsense mutation R168X (Mecp2(R168X/+)). MeCP2 T158A shows decreased binding to methylated DNA, while MeCP2 R168X retains the capacity to bind methylated DNA but lacks the ability to recruit complexes required for transcriptional repression. We found that both Mecp2(T158A/+) and Mecp2(R168X/+) heterozygotes display augmented hypoxic ventilatory responses and depressed hypercapnic responses, compared to wild-type controls. Interestingly, the incidence of apnea was much greater in Mecp2(R168X/+) heterozygotes, 189 per hour, than Mecp2(T158A/+) heterozygotes, 41 per hour. These results demonstrate that different RTT mutations lead to distinct respiratory phenotypes, suggesting that characterization of the respiratory phenotype may reveal functional differences between MeCP2 mutations and provide insights into the pathophysiology of RTT.
Copyright © 2014 IBRO. All rights reserved.

Entities:  

Keywords:  MeCP2; Rett syndrome; apnea; hypercapnia; hypoxia; transcriptional repression domain

Mesh:

Substances:

Year:  2014        PMID: 24626160      PMCID: PMC4097951          DOI: 10.1016/j.neuroscience.2014.02.043

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  43 in total

1.  Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome.

Authors:  Debra E Weese-Mayer; Steven P Lieske; Christina M Boothby; Anna S Kenny; Heather L Bennett; Jean M Silvestri; Jan-Marino Ramirez
Journal:  Pediatr Res       Date:  2006-08-28       Impact factor: 3.756

2.  Management of a severe forceful breather with Rett syndrome using carbogen.

Authors:  Eric E J Smeets; Peter O O Julu; Dick van Waardenburg; Ingegerd Witt Engerström; Stig Hansen; Flora Apartopoulos; Leopold M G Curfs; Connie T R M Schrander-Stumpel
Journal:  Brain Dev       Date:  2006-06-09       Impact factor: 1.961

3.  Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice.

Authors:  Jean-Charles Viemari; Jean-Christophe Roux; Andrew K Tryba; Véronique Saywell; Henri Burnet; Fernando Peña; Sébastien Zanella; Michelle Bévengut; Magali Barthelemy-Requin; Laura B K Herzing; Anne Moncla; Josette Mancini; Jan-Marino Ramirez; Laurent Villard; Gérard Hilaire
Journal:  J Neurosci       Date:  2005-12-14       Impact factor: 6.167

Review 4.  Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth.

Authors:  David M Katz; Mathias Dutschmann; Jan-Marino Ramirez; Gérard Hilaire
Journal:  Respir Physiol Neurobiol       Date:  2009-04-24       Impact factor: 1.931

5.  A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos.

Authors:  Irina Stancheva; Anne L Collins; Ingatia B Van den Veyver; Huda Zoghbi; Richard R Meehan
Journal:  Mol Cell       Date:  2003-08       Impact factor: 17.970

6.  Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice.

Authors:  Amy Lawson-Yuen; Daniel Liu; Liqun Han; Zhichun I Jiang; Guochuan E Tsai; Alo C Basu; Jonathan Picker; Jiamin Feng; Joseph T Coyle
Journal:  Brain Res       Date:  2007-08-24       Impact factor: 3.252

7.  Early breathing defects after moderate hypoxia or hypercapnia in a mouse model of Rett syndrome.

Authors:  Nicolas Voituron; Sébastien Zanella; Clément Menuet; Mathias Dutschmann; Gérard Hilaire
Journal:  Respir Physiol Neurobiol       Date:  2009-06-11       Impact factor: 1.931

8.  Anxiety-related mechanisms of respiratory dysfunction in a mouse model of Rett syndrome.

Authors:  Jun Ren; Xiuqing Ding; Gregory D Funk; John J Greer
Journal:  J Neurosci       Date:  2012-11-28       Impact factor: 6.167

Review 9.  The role of MeCP2 in the brain.

Authors:  Jacky Guy; Hélène Cheval; Jim Selfridge; Adrian Bird
Journal:  Annu Rev Cell Dev Biol       Date:  2011-06-29       Impact factor: 13.827

Review 10.  Preclinical research in Rett syndrome: setting the foundation for translational success.

Authors:  David M Katz; Joanne E Berger-Sweeney; James H Eubanks; Monica J Justice; Jeffrey L Neul; Lucas Pozzo-Miller; Mary E Blue; Diana Christian; Jacqueline N Crawley; Maurizio Giustetto; Jacky Guy; C James Howell; Miriam Kron; Sacha B Nelson; Rodney C Samaco; Laura R Schaevitz; Coryse St Hillaire-Clarke; Juan L Young; Huda Y Zoghbi; Laura A Mamounas
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

View more
  19 in total

1.  The Pathophysiology of Rett Syndrome With a Focus on Breathing Dysfunctions.

Authors:  Jan-Marino Ramirez; Marlusa Karlen-Amarante; Jia-Der Ju Wang; Nicholas E Bush; Michael S Carroll; Debra E Weese-Mayer; Alyssa Huff
Journal:  Physiology (Bethesda)       Date:  2020-11-01

2.  Reduced computational modelling of Kölliker-Fuse contributions to breathing patterns in Rett syndrome.

Authors:  Samuel Wittman; Ana Paula Abdala; Jonathan E Rubin
Journal:  J Physiol       Date:  2019-04-16       Impact factor: 5.182

3.  Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome-like phenotypes.

Authors:  Janine M Lamonica; Deborah Y Kwon; Darren Goffin; Polina Fenik; Brian S Johnson; Yue Cui; Hengyi Guo; Sigrid Veasey; Zhaolan Zhou
Journal:  J Clin Invest       Date:  2017-04-10       Impact factor: 14.808

4.  Mecp2 Disruption in Rats Causes Reshaping in Firing Activity and Patterns of Brainstem Respiratory Neurons.

Authors:  Yang Wu; Ningren Cui; Hao Xing; Weiwei Zhong; Colin Arrowood; Christopher M Johnson; Chun Jiang
Journal:  Neuroscience       Date:  2018-11-17       Impact factor: 3.590

5.  Progressive Changes in a Distributed Neural Circuit Underlie Breathing Abnormalities in Mice Lacking MeCP2.

Authors:  Teng-Wei Huang; Mikhail Y Kochukov; Christopher S Ward; Jonathan Merritt; Kaitlin Thomas; Tiffani Nguyen; Benjamin R Arenkiel; Jeffrey L Neul
Journal:  J Neurosci       Date:  2016-05-18       Impact factor: 6.167

6.  Defects in brainstem neurons associated with breathing and motor function in the Mecp2R168X/Y mouse model of Rett syndrome.

Authors:  Christopher M Johnson; Weiwei Zhong; Ningren Cui; Yang Wu; Hao Xing; Shuang Zhang; Chun Jiang
Journal:  Am J Physiol Cell Physiol       Date:  2016-09-21       Impact factor: 4.249

7.  Diurnal variation in autonomic regulation among patients with genotyped Rett syndrome.

Authors:  Michael Sean Carroll; Jan-Marino Ramirez; Debra E Weese-Mayer
Journal:  J Med Genet       Date:  2020-03-10       Impact factor: 6.318

Review 8.  Neurochemistry of the Kölliker-Fuse nucleus from a respiratory perspective.

Authors:  Adrienn G Varga; Sebastian N Maletz; Jordan T Bateman; Brandon T Reid; Erica S Levitt
Journal:  J Neurochem       Date:  2020-06-10       Impact factor: 5.546

9.  Deficiency of GABAergic synaptic inhibition in the Kölliker-Fuse area underlies respiratory dysrhythmia in a mouse model of Rett syndrome.

Authors:  Ana Paula Abdala; Marie A Toward; Mathias Dutschmann; John M Bissonnette; Julian F R Paton
Journal:  J Physiol       Date:  2015-12-14       Impact factor: 5.182

10.  Kir 5.1-dependent CO2 /H+ -sensitive currents contribute to astrocyte heterogeneity across brain regions.

Authors:  Kelsey C Patterson; Uri Kahanovitch; Christopher M Gonçalves; John J Hablitz; Alexander Staruschenko; Daniel K Mulkey; Michelle L Olsen
Journal:  Glia       Date:  2020-08-31       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.